Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Steroid Lawsuit Filed Against New England Compounding Company (NECC) by Meningitis Lawyers

PritzkerOlsen P.A.
Posted on: 13 Oct 12

Attorneys Fred Pritzker, Elliot Olsen and Ryan Osterholm have filed a lawsuit against New England Compounding Pharmacy, Inc., dba New England Compounding Center, (NECC) on behalf of a woman (Plaintiff) who had methylprednisolone acetate, a steroid produced by NECC, injected into the epidural space in her lumbar spine on August 1, 2012, at MAPS Pain Clinic in Edina, MN. The suit was filed in the United States District Court for the District of Minnesota.

On October 7, 2012, Plaintiff was informed by the Minnesota Department of Health that her injection of methylprednisolone acetate, a steroid, was part of a lot that had been recalled by NECC for potential contamination with Aspergillus or Exserohilum. As of October 12, 2012, the CDC has identified 185 cases of fungal meningitis in 12 states, including 14 deaths, associated with injections of recalled NECC methylprednisolone acetate.

Experiencing symptoms of meningitis, including headaches and neck pain, on October 8, 2012, the Plaintiff went to the emergency room at St. Francis Hospital in Shakopee, Minnesota. While hospitalized, she received a CT scan, IV medications for pain and anxiety, and a lumbar puncture (spinal tap), a painful procedure where a large needle is placed into the subarachnoid space in the spinal canal of the low back and fluid is withdrawn from the space with the syringe.

The steroid lawsuit seeks money damages in an amount exceeding $75,000.00.

The complaint filed in this case alleges that NECC sold pharmaceuticals in bulk in 2011 and 2012 despite the lack of a license to do so and in violation of federal law. It also alleges that the company produced and sold methylprednisolone acetate steroid products that were adulterated with Exserohilum and Aspergillus, dangerous pathogens that can cause illness and death.

“We are representing other patients who had epidural spinal injections of methylprednisolone acetate made by New England Compounding Center,” said Pritzker. “NECC had a duty to sell steroid medication that was safe to inject into patients. Because it did not, the company should be held accountable, and civil lawsuits like the one we filed today are meant to do that.”

Pritzker, Olsen and Osterholm are attorneys with PritzkerOlsen, P.A., a national product safety law firm that represents clients throughout the United States. The firm has obtained some of the largest verdicts and settlements in product liability cases, including a recent $40,000,000 recovery for clients injured by another medical product. Pritzker and Olsen also successfully represented the family of a woman who died from a medication made by another compounding pharmacy in a wrongful death lawsuit. Attorneys Pritzker, Olsen and Osterholm can be reached regarding a meningitis lawsuit at 1-888-377-8900 (toll free). More steroid meningitis lawsuit information can be found on their website www.pritzkerlaw.com. The firm has offices in Minneapolis, MN.

Business Wire
http://www.businesswire.com/

Last updated on: 13/10/2012

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.